drugset / Trial / NCT00301236

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

NCT00301236

Phase 3 Completed 252 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.

Timeline

Start
2006-02
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject dexmethylphenidate Unknown